Literature DB >> 12117900

Immunosuppression, IBD, and risk of lymphoma.

J R Bebb, G P Aithal, R P H Logan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12117900      PMCID: PMC1773319          DOI: 10.1136/gut.51.2.296

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  6 in total

Review 1.  Review article: does the use of immunosuppressive therapy in inflammatory bowel disease increase the risk of developing lymphoma?

Authors:  J R Bebb; R P Logan
Journal:  Aliment Pharmacol Ther       Date:  2001-12       Impact factor: 8.171

2.  Azathioprine for maintenance of remission in Crohn's disease: benefits outweigh the risk of lymphoma.

Authors:  J D Lewis; J S Schwartz; G R Lichtenstein
Journal:  Gastroenterology       Date:  2000-06       Impact factor: 22.682

Review 3.  Review article: the risk of lymphoma associated with inflammatory bowel disease and immunosuppressive treatment.

Authors:  G P Aithal; J C Mansfield
Journal:  Aliment Pharmacol Ther       Date:  2001-08       Impact factor: 8.171

4.  Cancer incidence in five continents. Volume V.

Authors: 
Journal:  IARC Sci Publ       Date:  1987

5.  Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment.

Authors:  L J Kinlen
Journal:  Am J Med       Date:  1985-01-21       Impact factor: 4.965

6.  Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients.

Authors:  G Opelz; R Henderson
Journal:  Lancet       Date:  1993 Dec 18-25       Impact factor: 79.321

  6 in total
  1 in total

1.  Nonlinear dose-response relationship in the immune system following exposure to ionizing radiation: mechanisms and implications.

Authors:  Shu-Zheng Liu
Journal:  Nonlinearity Biol Toxicol Med       Date:  2003-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.